UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 22, 2022 4:00 P.M.

Form:	S-3
CIK: 0001427925 Company Name: ACELRX PHARMACEUTICALS INC File Number: 333-268396